Literature DB >> 20445955

Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Tobias Derfuss1, Chris Linington, Reinhard Hohlfeld, Edgar Meinl.   

Abstract

Multiple sclerosis is thought to be an autoimmune-mediated disease of the central nervous system. For many years, T-cells were regarded as the key players in the pathogenesis, and myelin of white matter was considered as the main victim. However, research during recent years showed a more complex picture. Besides T-cells, also B-cells, antibodies and the innate immunity contribute to the tissue damage. Modern imaging techniques and neuropathological examinations showed that not only myelin but also axons, cortical neurons and nodes of Ranvier are damaged. The autoimmune targets of this widespread injury are so far not known. The identification of the axo-glial proteins contactin-2 and neurofascin provides excellent examples how antibodies can induce axonal injury at the node of Ranvier and how T-cells can destruct cortical integrity. This review will discuss the pathogenic implications of an autoimmune response against these newly discovered antigens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445955     DOI: 10.1007/s00109-010-0632-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  96 in total

1.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Infectious causes of multiple sclerosis.

Authors:  Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

3.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Authors:  Lars Bö; Jeroen J G Geurts; Paul van der Valk; Chris Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2007-01

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

6.  The human TAX1 gene encoding the axon-associated cell adhesion molecule TAG-1/axonin-1: genomic structure and basic promoter.

Authors:  S V Kozlov; R J Giger; T Hasler; E Korvatska; D F Schorderet; P Sonderegger
Journal:  Genomics       Date:  1995-11-20       Impact factor: 5.736

7.  Remyelination protects axons from demyelination-associated axon degeneration.

Authors:  K A Irvine; W F Blakemore
Journal:  Brain       Date:  2008-05-18       Impact factor: 13.501

Review 8.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

9.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  25 in total

Review 1.  Development of anti-CD20 therapy for multiple sclerosis.

Authors:  Beatrix Bartok; Gregg J Silverman
Journal:  Exp Cell Res       Date:  2011-04-12       Impact factor: 3.905

2.  Fibronectin type III-like domains of neurofascin-186 protein mediate gliomedin binding and its clustering at the developing nodes of Ranvier.

Authors:  Marilyne Labasque; Jérôme J Devaux; Christian Lévêque; Catherine Faivre-Sarrailh
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

3.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

4.  Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.

Authors:  Anna Boronat; María Sepúlveda; Sara Llufriu; Lidia Sabater; Yolanda Blanco; Iñigo Gabilondo; Nuria Solà; Pablo Villoslada; Josep Dalmau; Francesc Graus; Albert Saiz
Journal:  J Neuroimmunol       Date:  2012-01-14       Impact factor: 3.478

Review 5.  Immunopathological Factors Associated with Disability in Multiple Sclerosis.

Authors:  Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

6.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

7.  Potassium channel KIR4.1 as an immune target in multiple sclerosis.

Authors:  Rajneesh Srivastava; Muhammad Aslam; Sudhakar Reddy Kalluri; Lucas Schirmer; Dorothea Buck; Björn Tackenberg; Veit Rothhammer; Andrew Chan; Ralf Gold; Achim Berthele; Jeffrey L Bennett; Thomas Korn; Bernhard Hemmer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

8.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

9.  Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors.

Authors:  Fei Song; Manoj Bandara; Harvinder Deol; Jeffrey A Loeb; Joyce Benjamins; Robert P Lisak
Journal:  J Neuroimmunol       Date:  2013-06-12       Impact factor: 3.478

10.  Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair.

Authors:  Stephanie Devaux; Dasa Cizkova; Jusal Quanico; Julien Franck; Serge Nataf; Laurent Pays; Lena Hauberg-Lotte; Peter Maass; Jan H Kobarg; Firas Kobeissy; Céline Mériaux; Maxence Wisztorski; Lucia Slovinska; Juraj Blasko; Viera Cigankova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2016-06-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.